Treating cancer through Psorinum way

Psorinum therapy is an active-immunotherapeutic anti-cancer treatment against six types of cancer-liver, gall bladder, stomach, pancreatic, lung and esophagus.

The 31-year-old Uttam Sana, a Bangladeshi by origin, was in Uttar Pradesh when he was first diagnosed with stage-IV Liver Cancer in early 2011.

Being a construction labour, the financial hardships did not allow him to seek cancer treatment through conventional chemotherapy.

Sana then was forced to look for an alternative treatment that led to him to adopt much cheaper Psorinum therapy for his treatment.

Soon after Sana's his diagnosis, he was shifted to West Bengal at his in-law’s house at Haringhata, Nadia. Talking to TSI he said, “As soon I got to know about the cancer, I consulted an oncologist from Krishnanagar. And without sensing my financial condition he prescribed a three dose of vaccination that cost about 3 lakhs.”

But luckily Sana was informed about Dr. Aradeep Chatterjee and his Psorinum Therapy centre, Critical Cancer Management Research Centre and Clinic (CCMRCC) at Lake Town, Kolkata.

For Uttam, the clinical trial of Psorinum therapy started on April 2011. “Sana's tumor remission was observed within six months of starting the treatment. After the treatment his condition improved and now he is asymptomatic and leading a normal life,” confirmed Dr. Aradeep Chatterjee.

Same is the story of Sushanta Roy. In May 2011, at the age of 72 years, he was diagnosed with stage-IV urinary bladder cancer. Similarly, he too couldn’t avail the highly expensive conventional cancer treatment and enrolled himself into Psorinum and was cured successfully.

Explaining about Psorinum Therapy, Dr. Chatterjee said, “Psorinum therapy is an active-immunotherapeutic anti-cancer treatment against six types of cancer-liver, gall bladder, stomach, pancreatic, lung and esophagus. A diluted alcoholic extract of pus found in scabies vesicles Psorinum-6x is our key medicine. By which specialized killer cells are developed in our body. Interestingly these natural killer cells can easily distinguish the normal cells from cancer cells and work accordingly.”

Chatterjee further revealed, “Most of the time we get the patient minimum at Stage- III. And it’s quite obvious that sooner we get, the chances of higher-survival arises. But there stands some ethical issues too. If any patient is found at surgical advisory state, we can’t follow the alternative way. And we don’t have any competition with the conventional treatments either.”

According to Chatterjee, Psorinum Therapy is an oral treatment and most of the cancer patients can continue this while staying home and therefore hospitalization is less required.

Undoubtedly, this is completely a new phenomenon of cancer-treatment particularly in India. However, University of Texus, having world’s no one cancer hospital, has already started this therapy at clinical trial. The research details of this new therapy were reviewed by world’s largest oncology organization, American Society of Clinical Oncology (ASCO) and published in the world’s top-rated cancer journals, including the Journal of Clinical Oncology and Journal of Thoracic Oncology.

Now the question arises that what is the success rate of Psorinum Therapy and how much it’s reliable? According to the Journal of Clinical Oncology, in case of pancreatic cancer, the overall five-year survival success rate under Psorinum Therapy is 39 percent in comparison to patients undergoing conventional cancer treatments. In case of Liver, Gallbladder, Stomach, Lung, the comparative success rate is 44:9, 38:13, 38:23 and 45:16 respectively.

Dr. Jaydeep Biswas, the Director of Chittaranjan Cancer Hospital is also quite optimistic regarding this alternative treatment. “For the last 15 years or so I have been there to evaluate the outcome of this particular therapy and the fact-findings are really exciting. Several global and Indian oncology forums have supported the clinical efficiency of Psorinum-6X and confirmed that it has no adverse side effects,” he said.

Suniti Kumar Biswas, who at the age of 81 was diagnosed with rarest of the rare stage-IV male breast cancer in 2011 (accounting only about 1 percent of all the breast cancers), revealed that Psorinum therapy helped him to get cured in three months.